BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 16940179)

  • 1. In vivo requirement of the small subunit of U2AF for recognition of a weak 3' splice site.
    Pacheco TR; Coelho MB; Desterro JM; Mollet I; Carmo-Fonseca M
    Mol Cell Biol; 2006 Nov; 26(21):8183-90. PubMed ID: 16940179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional recognition of the 3' splice site AG by the splicing factor U2AF35.
    Wu S; Romfo CM; Nilsen TW; Green MR
    Nature; 1999 Dec; 402(6763):832-5. PubMed ID: 10617206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconstitution of exon-bridging activity with purified U2AF and U1 snRNP components.
    Cunningham TP; Hagan JP; Grabowski PJ
    Nucleic Acids Symp Ser; 1995; (33):218-9. PubMed ID: 8643375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetic analysis of the heterodimeric splicing factor U2AF: the RS domain on either the large or small Drosophila subunit is dispensable in vivo.
    Rudner DZ; Breger KS; Rio DC
    Genes Dev; 1998 Apr; 12(7):1010-21. PubMed ID: 9531538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for substrate-specific requirement of the splicing factor U2AF(35) and for its function after polypyrimidine tract recognition by U2AF(65).
    Guth S; Martínez C; Gaur RK; Valcárcel J
    Mol Cell Biol; 1999 Dec; 19(12):8263-71. PubMed ID: 10567551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A conditional role of U2AF in splicing of introns with unconventional polypyrimidine tracts.
    Sridharan V; Singh R
    Mol Cell Biol; 2007 Oct; 27(20):7334-44. PubMed ID: 17709389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct factor requirements for exonic splicing enhancer function and binding of U2AF to the polypyrimidine tract.
    Li Y; Blencowe BJ
    J Biol Chem; 1999 Dec; 274(49):35074-9. PubMed ID: 10574987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of mutant phenotypes and splicing defects demonstrates functional collaboration between the large and small subunits of the essential splicing factor U2AF in vivo.
    Webb CJ; Lakhe-Reddy S; Romfo CM; Wise JA
    Mol Biol Cell; 2005 Feb; 16(2):584-96. PubMed ID: 15548596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strict 3' splice site sequence requirements for U2 snRNP recruitment after U2AF binding underlie a genetic defect leading to autoimmune disease.
    Corrionero A; Raker VA; Izquierdo JM; Valcárcel J
    RNA; 2011 Mar; 17(3):401-11. PubMed ID: 21233219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hnRNP A1 proofreads 3' splice site recognition by U2AF.
    Tavanez JP; Madl T; Kooshapur H; Sattler M; Valcárcel J
    Mol Cell; 2012 Feb; 45(3):314-29. PubMed ID: 22325350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An extended U2AF(65)-RNA-binding domain recognizes the 3' splice site signal.
    Agrawal AA; Salsi E; Chatrikhi R; Henderson S; Jenkins JL; Green MR; Ermolenko DN; Kielkopf CL
    Nat Commun; 2016 Mar; 7():10950. PubMed ID: 26952537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual function for U2AF(35) in AG-dependent pre-mRNA splicing.
    Guth S; Tange TØ; Kellenberger E; Valcárcel J
    Mol Cell Biol; 2001 Nov; 21(22):7673-81. PubMed ID: 11604503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA binding activity of heterodimeric splicing factor U2AF: at least one RS domain is required for high-affinity binding.
    Rudner DZ; Breger KS; Kanaar R; Adams MD; Rio DC
    Mol Cell Biol; 1998 Jul; 18(7):4004-11. PubMed ID: 9632785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splicing inhibition of U2AF65 leads to alternative exon skipping.
    Cho S; Moon H; Loh TJ; Jang HN; Liu Y; Zhou J; Ohn T; Zheng X; Shen H
    Proc Natl Acad Sci U S A; 2015 Aug; 112(32):9926-31. PubMed ID: 26216990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. U2 small nuclear ribonucleoprotein particle (snRNP) auxiliary factor of 65 kDa, U2AF65, can promote U1 snRNP recruitment to 5' splice sites.
    Förch P; Merendino L; Martínez C; Valcárcel J
    Biochem J; 2003 May; 372(Pt 1):235-40. PubMed ID: 12558503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of U2AF(6), a splicing factor related to U2AF(35).
    Shepard J; Reick M; Olson S; Graveley BR
    Mol Cell Biol; 2002 Jan; 22(1):221-30. PubMed ID: 11739736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate-dependent differences in U2AF requirement for splicing in adenovirus-infected cell extracts.
    Lützelberger M; Backström E; Akusjärvi G
    J Biol Chem; 2005 Jul; 280(27):25478-84. PubMed ID: 15899895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic mRNA profiling reveals compensatory mechanisms for the requirement of the essential splicing factor U2AF.
    Sridharan V; Heimiller J; Singh R
    Mol Cell Biol; 2011 Feb; 31(4):652-61. PubMed ID: 21149581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the small subunit of the Drosophila U2AF splicing factor cause lethality and developmental defects.
    Rudner DZ; Kanaar R; Breger KS; Rio DC
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10333-7. PubMed ID: 8816800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the Caenorhabditis elegans U2AF large subunit UAF-1 alter the choice of a 3' splice site in vivo.
    Ma L; Horvitz HR
    PLoS Genet; 2009 Nov; 5(11):e1000708. PubMed ID: 19893607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.